| Fair values of financial instruments not carried at fair value and bases of valuation - assets |
| | | | | | | | | Financial instruments carried at fair value and bases of valuation | | | | | | | | | | | | | | | | | | | | | | Recurring fair value measurements at 31 Dec | | | | | | | | | | | | | | | | | | | | | | | | | | | Financial assets designated and otherwise mandatorily measured at fair value through profit or loss | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Financial liabilities designated at fair value | | | | | | | | | | | | | | | | | |
There were no material transfers between Level 1 and Level 2 during the reporting period. The table below provides the fair value levelling of assets held for sale and liabilities of disposal groups that have been classified as held for sale in accordance with IFRS 5. For further details, see Note 23. | | | | | | | | | Financial instruments carried at fair value and bases of valuation – assets and liabilities held for sale | | | | | | | | | | | | | | | | | | | | | | Recurring fair value measurements at 31 Dec | | | | | | | | | | | | | | | | | | | | | | | | | | | Financial assets designated and otherwise mandatorily measured at fair value through profit or loss | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Financial liabilities designated at fair value | | | | | | | | | | | | | | | | | |
| | | | | | | | | | Financial instruments measured at fair value using a valuation technique with significant unobservable inputs – Level 3 | | | | | | | Designated and otherwise mandatorily measured at fair value through profit or loss | | | | | | | | | | | | | | | | | Private equity including strategic investments | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Private equity including strategic investments | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | Movement in Level 3 financial instruments | | | | | | | Designated and otherwise mandatorily measured at fair value through profit or loss | | | | | | | | | | | | | | | | | | | | | Total gains/(losses) recognised in profit or loss | | | | | | | | – net income/(losses) from financial instruments held for trading or managed on a fair value basis | | | | | | | | – net income from assets and liabilities of insurance businesses, including related derivatives, measured at fair value through profit or loss | | | | | | | | | | | | | | | | Total gains/(losses) recognised in other comprehensive income (‘OCI’)1 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Unrealised gains/(losses) recognised in profit or loss relating to assets and liabilities held at 31 Dec 2025 | | | | | | | | – net income/(losses) from financial instruments held for trading or managed on a fair value basis | | | | | | | | – net income from assets and liabilities of insurance businesses, including related derivatives, measured at fair value through profit or loss | | | | | | | | | | | | | | | |
| | | | | | | | Movement in Level 3 financial instruments (continued) | | | | | | | Designated and otherwise mandatorily measured at fair value through profit or loss | | | | | | | | | | | | | | | | | | | | | Total gains/(losses) recognised in profit or loss | | | | | | | | – net income/(losses) from financial instruments held for trading or managed on a fair value basis | | | | | | | | – net income from assets and liabilities of insurance businesses, including related derivatives, measured at fair value through profit or loss | | | | | | | | | | | | | | | | Total gains/(losses) recognised in other comprehensive income (‘OCI’)1 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Unrealised gains/(losses) recognised in profit or loss relating to assets and liabilities held at 31 Dec 2024 | | | | | | | | – net income/(losses) from financial instruments held for trading or managed on a fair value basis | | | | | | | | – net income from assets and liabilities of insurance businesses, including related derivatives, measured at fair value through profit or loss | | | | | | | | | | | | | | | |
1Included in ‘financial investments: fair value gains/(losses)’ in the year and ‘exchange differences’ in the consolidated statement of comprehensive income. 2Purchases were predominantly due to the growth of the Insurance business over the period. 3Includes $2.3bn of transfers in representing enhancements to the application of the levelling methodology, primarily impacting the Insurance business. | | | | | | | Basis of valuing HSBC Holdings’ financial assets and liabilities measured at fair value | | | | | | | | | | | | | | | | | | Recurring fair value measurement | | | | | | | | | | | | | | | | | | | | | Financial assets with HSBC undertakings designated and otherwise mandatorily measured at fair value | | | | | | | | | | | | | | | | | | | | | Financial liabilities designated at fair value | | | | | | | | | | | | | |
| | | | | | Fair values of financial instruments not carried at fair value and bases of valuation | | | | | | Quoted market price Level 1 | | Significant unobservable inputs Level 3 | | | | | | | | | | | | | | | | | | | | Loans and advances to banks | | | | | | Loans and advances to customers1 | | | | | | Reverse repurchase agreements – non-trading | | | | | | Financial investments – at amortised cost | | | | | | | | | | | | | | | | | | | | | | | | Repurchase agreements – non-trading | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Loans and advances to banks | | | | | | Loans and advances to customers | | | | | | Reverse repurchase agreements – non-trading | | | | | | Financial investments – at amortised cost | | | | | | | | | | | | | | | | | | | | | | | | Repurchase agreements – non-trading | | | | | | | | | | | | | | | | | |
1Includes loans and advances to customers with observable inputs and short maturities. | | | | | | Fair values of financial instruments not carried at fair value and bases of valuation – assets and disposal groups held for sale | | | | | | Quoted market price Level 1 | Observable inputs Level 2 | Significant unobservable inputs Level 3 | | | | | | | | | | | | | | | | | | | | Loans and advances to banks | | | | | | Loans and advances to customers | | | | | | Reverse repurchase agreements – non-trading | | | | | | Financial investments – at amortised cost | | | | | | | | | | | | | | | | | | | | | | | | Repurchase agreements – non-trading | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Loans and advances to banks | | | | | | Loans and advances to customers | | | | | | Reverse repurchase agreements – non-trading | | | | | | Financial investments – at amortised cost | | | | | | | | | | | | | | | | | | | | | | | | Repurchase agreements – non-trading | | | | | | | | | | | | | | | | | |
| | | | | Fair values of HSBC Holdings’ financial instruments not carried at fair value on the balance sheet | | | | | | | | | | | | | | | | | | | Loans and advances to HSBC undertakings | | | | | Financial investments – at amortised cost | | | | | | | | | | | | | | | | | | | |
1Fair values (other than Financial investments which are Level 1) were determined using valuation techniques with observable inputs (Level 2).
|
| Fair values of financial instruments not carried at fair value and bases of valuation - liabilities |
| | | | | | | | | Financial instruments carried at fair value and bases of valuation | | | | | | | | | | | | | | | | | | | | | | Recurring fair value measurements at 31 Dec | | | | | | | | | | | | | | | | | | | | | | | | | | | Financial assets designated and otherwise mandatorily measured at fair value through profit or loss | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Financial liabilities designated at fair value | | | | | | | | | | | | | | | | | |
There were no material transfers between Level 1 and Level 2 during the reporting period. The table below provides the fair value levelling of assets held for sale and liabilities of disposal groups that have been classified as held for sale in accordance with IFRS 5. For further details, see Note 23. | | | | | | | | | Financial instruments carried at fair value and bases of valuation – assets and liabilities held for sale | | | | | | | | | | | | | | | | | | | | | | Recurring fair value measurements at 31 Dec | | | | | | | | | | | | | | | | | | | | | | | | | | | Financial assets designated and otherwise mandatorily measured at fair value through profit or loss | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Financial liabilities designated at fair value | | | | | | | | | | | | | | | | | |
| | | | | | | | | | Financial instruments measured at fair value using a valuation technique with significant unobservable inputs – Level 3 | | | | | | | Designated and otherwise mandatorily measured at fair value through profit or loss | | | | | | | | | | | | | | | | | Private equity including strategic investments | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Private equity including strategic investments | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | Movement in Level 3 financial instruments | | | | | | | Designated and otherwise mandatorily measured at fair value through profit or loss | | | | | | | | | | | | | | | | | | | | | Total gains/(losses) recognised in profit or loss | | | | | | | | – net income/(losses) from financial instruments held for trading or managed on a fair value basis | | | | | | | | – net income from assets and liabilities of insurance businesses, including related derivatives, measured at fair value through profit or loss | | | | | | | | | | | | | | | | Total gains/(losses) recognised in other comprehensive income (‘OCI’)1 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Unrealised gains/(losses) recognised in profit or loss relating to assets and liabilities held at 31 Dec 2025 | | | | | | | | – net income/(losses) from financial instruments held for trading or managed on a fair value basis | | | | | | | | – net income from assets and liabilities of insurance businesses, including related derivatives, measured at fair value through profit or loss | | | | | | | | | | | | | | | |
| | | | | | | | Movement in Level 3 financial instruments (continued) | | | | | | | Designated and otherwise mandatorily measured at fair value through profit or loss | | | | | | | | | | | | | | | | | | | | | Total gains/(losses) recognised in profit or loss | | | | | | | | – net income/(losses) from financial instruments held for trading or managed on a fair value basis | | | | | | | | – net income from assets and liabilities of insurance businesses, including related derivatives, measured at fair value through profit or loss | | | | | | | | | | | | | | | | Total gains/(losses) recognised in other comprehensive income (‘OCI’)1 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Unrealised gains/(losses) recognised in profit or loss relating to assets and liabilities held at 31 Dec 2024 | | | | | | | | – net income/(losses) from financial instruments held for trading or managed on a fair value basis | | | | | | | | – net income from assets and liabilities of insurance businesses, including related derivatives, measured at fair value through profit or loss | | | | | | | | | | | | | | | |
1Included in ‘financial investments: fair value gains/(losses)’ in the year and ‘exchange differences’ in the consolidated statement of comprehensive income. 2Purchases were predominantly due to the growth of the Insurance business over the period. 3Includes $2.3bn of transfers in representing enhancements to the application of the levelling methodology, primarily impacting the Insurance business. | | | | | | | Basis of valuing HSBC Holdings’ financial assets and liabilities measured at fair value | | | | | | | | | | | | | | | | | | Recurring fair value measurement | | | | | | | | | | | | | | | | | | | | | Financial assets with HSBC undertakings designated and otherwise mandatorily measured at fair value | | | | | | | | | | | | | | | | | | | | | Financial liabilities designated at fair value | | | | | | | | | | | | | |
| | | | | | Fair values of financial instruments not carried at fair value and bases of valuation | | | | | | Quoted market price Level 1 | | Significant unobservable inputs Level 3 | | | | | | | | | | | | | | | | | | | | Loans and advances to banks | | | | | | Loans and advances to customers1 | | | | | | Reverse repurchase agreements – non-trading | | | | | | Financial investments – at amortised cost | | | | | | | | | | | | | | | | | | | | | | | | Repurchase agreements – non-trading | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Loans and advances to banks | | | | | | Loans and advances to customers | | | | | | Reverse repurchase agreements – non-trading | | | | | | Financial investments – at amortised cost | | | | | | | | | | | | | | | | | | | | | | | | Repurchase agreements – non-trading | | | | | | | | | | | | | | | | | |
1Includes loans and advances to customers with observable inputs and short maturities. | | | | | | Fair values of financial instruments not carried at fair value and bases of valuation – assets and disposal groups held for sale | | | | | | Quoted market price Level 1 | Observable inputs Level 2 | Significant unobservable inputs Level 3 | | | | | | | | | | | | | | | | | | | | Loans and advances to banks | | | | | | Loans and advances to customers | | | | | | Reverse repurchase agreements – non-trading | | | | | | Financial investments – at amortised cost | | | | | | | | | | | | | | | | | | | | | | | | Repurchase agreements – non-trading | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Loans and advances to banks | | | | | | Loans and advances to customers | | | | | | Reverse repurchase agreements – non-trading | | | | | | Financial investments – at amortised cost | | | | | | | | | | | | | | | | | | | | | | | | Repurchase agreements – non-trading | | | | | | | | | | | | | | | | | |
| | | | | Fair values of HSBC Holdings’ financial instruments not carried at fair value on the balance sheet | | | | | | | | | | | | | | | | | | | Loans and advances to HSBC undertakings | | | | | Financial investments – at amortised cost | | | | | | | | | | | | | | | | | | | |
1Fair values (other than Financial investments which are Level 1) were determined using valuation techniques with observable inputs (Level 2).
|